{
    "clinical_study": {
        "@rank": "151252", 
        "arm_group": {
            "arm_group_label": "Supportive care (psychosocial intervention)", 
            "arm_group_type": "Experimental", 
            "description": "Patients participate in a multi-component intervention based on cognitive and behavioral principles comprising MBSR, an intervention to promote hopefulness, and a problem solving approach which navigates around obstacles or generates alternatives when goals become blocked. Additional topics may be covered as indicated by clinical need and patients goals. Biobehavioral components include addressing social and disease-specific quality of life, and pain education. Intensive treatment sessions continue weekly for 16 weeks followed by 2 biweekly and 2 monthly maintenance sessions."
        }, 
        "brief_summary": {
            "textblock": "This pilot clinical trial studies stress reduction in improving quality of life in patients\n      with recurrent gynecologic or breast cancer. Participating in a stress reduction program may\n      help improve quality of life in patients with gynecologic or breast cancer."
        }, 
        "brief_title": "Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer", 
        "condition": [
            "Anxiety Disorder", 
            "Depression", 
            "Fatigue", 
            "Leydig Cell Tumor", 
            "Ovarian Sarcoma", 
            "Ovarian Stromal Cancer", 
            "Pain", 
            "Peritoneal Carcinomatosis", 
            "Pseudomyxoma Peritonei", 
            "Recurrent Breast Cancer", 
            "Recurrent Cervical Cancer", 
            "Recurrent Endometrial Carcinoma", 
            "Recurrent Fallopian Tube Cancer", 
            "Recurrent Gestational Trophoblastic Tumor", 
            "Recurrent Ovarian Epithelial Cancer", 
            "Recurrent Ovarian Germ Cell Tumor", 
            "Recurrent Primary Peritoneal Cavity Cancer", 
            "Recurrent Uterine Sarcoma", 
            "Recurrent Vaginal Cancer", 
            "Recurrent Vulvar Cancer"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Anxiety Disorders", 
                "Breast Neoplasms", 
                "Carcinoma", 
                "Uterine Cervical Neoplasms", 
                "Depression", 
                "Depressive Disorder", 
                "Fatigue", 
                "Leydig Cell Tumor", 
                "Pseudomyxoma Peritonei", 
                "Trophoblastic Neoplasms", 
                "Vaginal Neoplasms", 
                "Vulvar Neoplasms", 
                "Peritoneal Neoplasms", 
                "Fallopian Tube Neoplasms", 
                "Neoplasms, Germ Cell and Embryonal", 
                "Germinoma", 
                "Ovarian Neoplasms", 
                "Endometrial Neoplasms", 
                "Neoplasms, Glandular and Epithelial", 
                "Gestational Trophoblastic Neoplasms", 
                "Sarcoma"
            ]
        }, 
        "detailed_description": {
            "textblock": "PRIMARY OBJECTIVES:\n\n      I. To refine the intervention. II. Test the acceptability, feasibility, and clinical\n      appropriateness of the intervention.\n\n      III. To provide a preliminary test of its efficacy.\n\n      OUTLINE:\n\n      Patients participate in a multi-component intervention based on cognitive and behavioral\n      principles comprising mindfulness-based stress reduction (MBSR), an intervention to promote\n      hopefulness, and a problem solving approach which navigates around obstacles or generates\n      alternatives when goals become blocked. Additional topics may be covered as indicated by\n      clinical need and patients goals. Biobehavioral components include addressing social and\n      disease-specific quality of life, and pain education. Intensive treatment sessions continue\n      weekly for 16 weeks followed by 2 biweekly and 2 monthly maintenance sessions.\n\n      After completion of study treatment, patients are followed up at 28 weeks."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosis of recurrent breast or gynecologic cancer (any site) with any disease-free\n             interval; second primary cancers do not meet this criterion\n\n          -  English speaking\n\n          -  Able and willing to give informed consent\n\n          -  To be considered for the blood and saliva collection, women must fulfill the\n             following secondary criteria:\n\n               -  Diagnosis of recurrent breast or ovarian cancer with any disease-free interval\n\n        Exclusion Criteria:\n\n          -  Residence > 70 miles from research site\n\n          -  Subnormal intellectual potential (diagnosis of mental retardation)\n\n          -  Progressive neurological or chronic, progressive, debilitating condition (e.g.,\n             dementia)\n\n          -  Non-ambulatory\n\n          -  Life expectancy less than 160 days, per the treating oncologist\n\n          -  Current suicide risk sufficient to preclude treatment on an outpatient basis\n\n          -  Chronic inflammatory or autoimmune disorder (e.g., rheumatoid arthritis, lupus)"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "48", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01764789", 
            "org_study_id": "OSU-10026", 
            "secondary_id": [
                "NCI-2012-01177", 
                "R21CA135005"
            ]
        }, 
        "intervention": [
            {
                "arm_group_label": "Supportive care (psychosocial intervention)", 
                "description": "Ancillary studies", 
                "intervention_name": "questionnaire administration", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Supportive care (psychosocial intervention)", 
                "description": "Patients will participate in a quality life assessment.", 
                "intervention_name": "quality-of-life assessment", 
                "intervention_type": "Procedure", 
                "other_name": [
                    "quality of life assessment", 
                    "Ancillary studies"
                ]
            }, 
            {
                "arm_group_label": "Supportive care (psychosocial intervention)", 
                "description": "Participate in multi-component biobehavioral intervention", 
                "intervention_name": "psychosocial assessment and care", 
                "intervention_type": "Procedure", 
                "other_name": [
                    "psychosocial assessment", 
                    "psychosocial assessment/care", 
                    "psychosocial care", 
                    "psychosocial care/assessment", 
                    "psychosocial studies"
                ]
            }, 
            {
                "arm_group_label": "Supportive care (psychosocial intervention)", 
                "description": "Participate in multi-component biobehavioral intervention", 
                "intervention_name": "behavioral intervention", 
                "intervention_type": "Behavioral", 
                "other_name": [
                    "Behavior Conditioning Therapy", 
                    "Behavior Therapy", 
                    "Behavioral Modification", 
                    "Behavioral Therapy", 
                    "Behavioral Treatment"
                ]
            }, 
            {
                "arm_group_label": "Supportive care (psychosocial intervention)", 
                "description": "A multi-component intervention based on cognitive and behavioral principles will be used. It combines effective intervention strategies selected for their relevance to patients with recurrent cancer.", 
                "intervention_name": "cognitive intervention", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Supportive care (psychosocial intervention)", 
                "description": "Participate in multi-component biobehavioral intervention", 
                "intervention_name": "educational intervention", 
                "intervention_type": "Other", 
                "other_name": "intervention, educational"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "psychological intervention", 
            "breast cancer", 
            "gynecologic cancer"
        ], 
        "lastchanged_date": "May 20, 2014", 
        "link": {
            "description": "The Jamesline", 
            "url": "http://cancer.osu.edu"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Columbus", 
                    "country": "United States", 
                    "state": "Ohio", 
                    "zip": "43210"
                }, 
                "name": "Ohio State University Medical Center"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Biobehavioral Intervention for Patients With Gynecologic or Breast Cancer Recurrence", 
        "overall_official": {
            "affiliation": "Ohio State University Comprehensive Cancer Center", 
            "last_name": "Barbara Andersen, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Quality of life as assessed by Short Form (SF)-36", 
            "measure": "Quality of life(QoL)", 
            "safety_issue": "No", 
            "time_frame": "up to 28 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01764789"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ohio State University Comprehensive Cancer Center", 
            "investigator_full_name": "Barbara Andersen", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Mood as assessed by the Profile of Mood States (POMS)", 
                "safety_issue": "No", 
                "time_frame": "Up to 28 weeks"
            }, 
            {
                "measure": "Depressive symptoms as assessed by the Center for Epidemiological Studies, Depression scale (CES-D)", 
                "safety_issue": "No", 
                "time_frame": "Up to 28 weeks"
            }, 
            {
                "measure": "Stress as assessed by the Impact of Event Scale (IES)", 
                "safety_issue": "No", 
                "time_frame": "Up to 28 weeks"
            }, 
            {
                "measure": "Pain as assessed by the Brief Pain Inventory (BPI)", 
                "safety_issue": "No", 
                "time_frame": "Up to 28 weeks"
            }, 
            {
                "measure": "Fatigue as assessed by the Fatigue Severity Index (FSI)", 
                "safety_issue": "No", 
                "time_frame": "Up to 28 weeks"
            }, 
            {
                "description": "Study participants will also collect saliva samples at home 4 times a day for 3 days. Saliva samples will be collected at the baseline, mid-treatment, post-treatment and 3-month follow-up assessments. These samples will be used to measure cortisol.", 
                "measure": "Diurnal cortisol slope", 
                "safety_issue": "No", 
                "time_frame": "Up to 28 weeks"
            }, 
            {
                "description": "Blood samples will be used to measure levels of inflammatory markers. Blood draws will be coordinated with the participants' regularly scheduled blood draws to minimize discomfort.", 
                "measure": "Inflammation", 
                "safety_issue": "No", 
                "time_frame": "Up to 28 weeks"
            }
        ], 
        "source": "Ohio State University Comprehensive Cancer Center", 
        "sponsors": {
            "collaborator": {
                "agency": "National Cancer Institute (NCI)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "Ohio State University Comprehensive Cancer Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2010", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}